Directory
>
Sergey Rakhilin
Sergey Rakhilin
Executive Director | Critical Path Institute (C-Path)
Brookline, Massachusetts, United States
Sergey Rakhilin
Summary
Sergey Rakhilin is an accomplished Executive Director in the biotech sector, currently leading initiatives at Critical Path Institute. With a robust background in drug discovery and development, he has held pivotal roles in both academic and corporate settings, including positions at Biogen Idec and Novartis. Sergey specializes in biologics, assay development, and protein engineering, demonstrating a hands-on leadership style that fosters innovation. His career is marked by a commitment to addressing complex health challenges, particularly in neurodegenerative and autoimmune diseases. Sergey is passionate about building biotech companies that leverage flexible technological platforms for therapeutic advancements. He holds a Ph.D. in Biochemistry from Lomonosov Moscow State University, and has cultivated a vast network of professionals throughout his career. His vision is to create impactful solutions that enhance patient outcomes in the biopharmaceutical landscape.
Sergey Rakhilin
Work Experience
Executive Director at
Critical Path Institute (C-Path)
March 2022 - Present
Director at
Curapath
October 2019 - March 2022
Director of Product Development at
PharmaIN, Corp.
October 2014 - October 2021
Chief Science Officer at
Generium
September 2013 - October 2014
Principal Scientist at
Biogen
June 2011 - August 2012
Lab Head/Research Investigator III at
Novartis
March 2006 - July 2011
Research Associate at
Rockefeller University
June 1998 - March 2006
Research Associate Assistant Professor at
The University of Chicago
June 1995 - May 1998
Research Associate at
The University of Chicago
June 1991 - May 1995
Sergey Rakhilin
Education
Московский Государственный Университет им. М.В. Ломоносова (МГУ) [факультет ВМК], Ph.D
January 1985 - January 1989
Moscow State University, Ms
January 1980 - January 1985
Postdoctoral fellow at the University of Chicago
January 1992
Frequently Asked Questions about Sergey Rakhilin
What is Sergey Rakhilin email address?
Sergey Rakhilin's primary email address is **********@hookelabs.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sergey Rakhilin work for?
Sergey Rakhilin is a Executive Director at Critical Path Institute (C-Path), a company specializing in Commercial physical research.
Where Sergey Rakhilin graduated from?
Sergey Rakhilin holds a degree in Biochemistry from Московский Государственный Университет им. М.В. Ломоносова (МГУ) [факультет ВМК].
How can I directly contact Sergey Rakhilin?
To contact Sergey Rakhilin directly, you can use the email address **********@hookelabs.com. Complete contact information is available upon registration with Muraena.
Is Sergey Rakhilin an immigrant?
Yes, Sergey Rakhilin is an immigrant and currently based in United States
Who is Sergey Rakhilin?
Sergey Rakhilin is an accomplished Executive Director in the biotech sector, currently leading initiatives at Critical Path Institute. With a robust background in drug discovery and development, he has held pivotal roles in both academic and corporate settings, including positions at Biogen Idec and Novartis. Sergey specializes in biologics, assay development, and protein engineering, demonstrating a hands-on leadership style that fosters innovation. His career is marked by a commitment to addressing complex health challenges, particularly in neurodegenerative and autoimmune diseases. Sergey is passionate about building biotech companies that leverage flexible technological platforms for therapeutic advancements. He holds a Ph.D. in Biochemistry from Lomonosov Moscow State University, and has cultivated a vast network of professionals throughout his career. His vision is to create impactful solutions that enhance patient outcomes in the biopharmaceutical landscape.
Sergey`s contact details
**********@hookelabs.com
*********@c-path.org
Colleagues
Vice President Global Affairs
Chief Of Staff
Chief Operating Officer
Executive Director, Critical Path for Rare Neurodegenerative Diseases (CP-RND)
Chief Science Officer
Chief Science Officer
Executive Director
Executive Director
Executive Director, Epro Consortium
Executive Director, eCOA Consortium